Clinical trials
Outcome Assessment clinical trials
Below are recruiting outcome assessment clinical trials, each written for real people, not researchers. We’re tracking 156 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07502885Recruiting
Study of walking in children with bone or soft tissue tumors
This study looks at how children with certain bone or soft tissue tumors walk after orthopedic surgery. It aims to understand and improve their movement and recovery.
Memphis, TennesseeAges 5–20 - NCT05134467Recruiting
Protocol-based weaning from the ventilator in ICU patients
This study looks at a step-by-step plan to help patients come off the breathing machine (mechanical ventilator) and checks how well it works. If you’re an ICU patient on the ventilator for at least two days, you may be eligible to follow their protocol.
SeoulAges 19–99 - NCT06521047Recruiting
Long-term follow-up for EXCELLENT trial participants
This study looks at the long-term health of people who took part in the EXCELLENT trial. If you finished that trial within the last 10 years, you may be able to join this study to help researchers understand how participants are doing over time.
Mulhouse, FranceAges 18 years+ - NCT07718425Recruiting
Endoscopic mastectomy surgery study
This study tests a new, less invasive surgery called endoscopic mastectomy for women who need breast removal. It aims to see how well the surgery works, how the breast looks and feels afterward, and whether nipple sensation is preserved.
Ponderano, BIAges 18–75 - NCT07532213Recruiting
Real-world outcomes of guselkumab for ulcerative colitis or Crohn's disease
This study tracks how well guselkumab (a biologic medication that blocks IL-23, a protein that drives inflammation) works for moderate-to-severe ulcerative colitis or Crohn's disease in everyday clinical practice. Researchers want to understand long-term benefits and safety in real patients.
BernAges 18 years+ - NCT06806488Recruiting
Marginal zone lymphoma patient study
This study looks at patients with marginal zone lymphoma who were diagnosed and treated at a specific hospital in Italy between 2012 and 2018. It aims to learn more about how the disease progresses and how patients respond to treatment.
Bologna, BolognaAges 18 years+ - NCT07227896Recruiting
Study of a new pump treatment for advanced Parkinson's
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
Georgetown, TexasAges 18–80 - NCT07212595RecruitingPhase 2
Amino acid therapy to protect kidneys after heart surgery in children
This trial is testing whether giving amino acids after heart surgery can help prevent kidney injury in children at high risk. If it works, it could offer a simple way to protect kidney function during recovery.
Cincinnati, OhioAges Up to 18 years - NCT07159711Recruiting
Heart monitoring study for esophageal cancer surgery
This study tests a non-invasive heart monitor (seismocardiography) to see if it can predict how well patients recover after esophageal cancer surgery. The goal is to improve surgical planning and outcomes.
GuildfordAges 18 years+ - NCT07148895Enrolling by invitation
Drain vs No Drain After Kids' Sistrunk Surgery
This study checks whether it's better to use a drain or not after Sistrunk surgery in children. The goal is to see if skipping a drain reduces complications and improves recovery.
Los Angeles, CaliforniaAges 3–17 - NCT07023757Enrolling by invitation
Age and healing after tooth extraction with PRF
This study looks at how age affects healing after a tooth is removed and replaced with a bone graft using Platelet-Rich Fibrin (PRF), a natural substance from your own blood that helps healing. It may help you if you need a molar removed and plan to get an implant later.
Ann Arbor, MichiganAges 20–80 - NCT06965374Recruiting
Study of a new Parkinson's injection and quality of life
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
Troina, EnnaAges 18 years+ - NCT06857539Recruiting
Assessing thinking and movement in high-risk infants
This study looks at how high-risk infants (especially those born early or with brain concerns) develop their thinking and movement skills over time, comparing them to healthy babies. The goal is to better understand and support their development.
CorkAges birth–4 months - NCT06581042Recruiting
Study of upadacitinib in adults with IBD in Belgium
This study looks at how adults with Crohn's disease or ulcerative colitis are doing after taking upadacitinib (Rinvoq) for at least 12 months. It helps doctors understand treatment patterns and outcomes in real-world settings.
Bonheiden, AntwerpenAges 18 years+ - NCT06479447Recruiting
Patient-reported PTSD screening study
This trial is testing a simple way to check for PTSD symptoms using patient-reported questionnaires. It aims to help people who haven't been screened recently get the care they need.
Chicago, IllinoisAges 18 years+ - NCT01762813Recruiting
Study of blood/tissue markers in colorectal cancer surgery patients
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
StavangerAges 18 years+ - NCT07414095Recruiting
Frailty assessment before liver transplant and outcomes
This study looks at how frail liver transplant candidates are before surgery and whether that affects their recovery afterward. Participants will complete simple physical and mental tasks to help doctors better understand their overall health before the transplant.
IzmirAges 18–65 - NCT07674004Recruiting
Testing a new flow diverter for brain aneurysms
This trial tests a special metal mesh tube, called a flow diverter, to treat unruptured brain aneurysms. The goal is to see how safe and effective it is for preventing strokes.
Zhengzhou, HenanAges 18–75 - NCT07345494Recruiting
YORVIPATH pregnancy and breastfeeding safety study
This study tracks the health of mothers and babies who were exposed to YORVIPATH (a medicine for hypoparathyroidism) around the time of pregnancy or while breastfeeding. It aims to understand if the medicine affects pregnancy outcomes or infant health.
Morgantown, West VirginiaAges 15–50 - NCT06966908Recruiting
Managing hepatitis B in non-specialty hospital settings
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
Guangzhou, GuangdongAges Any age - NCT06491862Recruiting
Real-world outcomes after first treatment for advanced lung cancer in Brazil
This study looks at real-world treatment patterns and outcomes for people with advanced non-squamous non-small cell lung cancer in Brazil after standard treatments have failed. It aims to understand what happens next and how well different approaches work in everyday practice.
Belo Horizonte, Minas GeraisAges 18 years+ - NCT06299748Recruiting
Efgartigimod safety study for pregnancy and breastfeeding
This study is for women who have taken efgartigimod (a medicine for certain autoimmune conditions) right before or during pregnancy, or while breastfeeding. Researchers will monitor moms, fetuses, and babies to check for side effects and ensure safety.
Morgantown, West VirginiaAges Any age - NCT05733091Recruiting
Study of symptoms and function after certain head and neck cancers
This study looks at how symptoms and everyday functioning change for people with cancers of the nose/sinuses, the throat behind the nose (nasopharynx), or nearby skull-base areas. It may help doctors understand what survivors experience and improve long-term care.
Houston, TexasAges 18 years+ - NCT05579548Recruiting
Study of Pegvaliase use in pregnancy and breastfeeding for PKU
This study looks at how taking Pegvaliase during pregnancy and breastfeeding affects pregnancy, baby health, and early infant outcomes in people with PKU. It may help improve care guidance for patients and babies exposed to Pegvaliase before birth.
Wilmington, North CarolinaAges Any age
Hear when a new Outcome Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for outcome assessment?
- Yes. Clin2 currently lists 156 recruiting outcome assessment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a outcome assessment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a outcome assessment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.